These patients were also further divided into three subtypes: 10 patients with primary hepatocellular carcinoma and a large amount of ascites (IIa), 10 patients with gastric or pancreatic cancer ...

However, 21 of 22 patients (95%) with cirrhotic ascites (groups Ib and Ic ... Serum α-fetoprotein (AFP), carcino-embryonic antigen and cancer antigen (CA) 19-9 were determined in all patients.

Indeed, with increasing cancer progression, the levels of regulatory T cells decreased in the lymph nodes and increased within the tumour tissue and ascites, indicating that regulatory T cells ...

Ascites is the buildup of fluid in the abdominal cavity, which often develops as a complication of liver disease. However, ...

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEMENT, LINDIS HAS GRANTED PHARMANOVIA ...

Catumaxomab, a first-in-class therapeutic, is specifically designed to treat malignant ascites in adults with certain types of cancer (epithelial cellular adhesion molecule (EpCAM)-positive ...